Circ_0038718 Promotes Colon Cancer Cell Malignant Progression Via the MiR-195-5p/Axin2 Signaling Axis and Also Effect Wnt/β-catenin Signal Pathway

Overview

Journal BMC Genomics

Publisher Biomed Central

Specialty Genetics

Date 2021 Oct 28

PMID 34706645

Citations 11

Authors

Haitao Gu

Zhiquan Xu

Jianbo Zhang

Yanbing Wei

Ling Cheng

Jijian Wang

Affiliations

Soon will be listed here.

Abstract

Objective: Colon cancer (CC) is one of the most common cancers whose progression is regulated by a number of factors, including circular RNAs (circRNAs). Nonetheless, circ_0038718 is a novel circRNA, and its regulatory mechanism in CC remains unclear.

Methods: Real-time quantitative PCR (qRT-PCR) was performed to detect the expression of circ_0038718, miR-195-5p and Axin2. Western blot was conducted to determine the protein expression of Axin2 and the key proteins on Wnt/β-catenin signaling pathway. Oligo (dT) primers and RNase R were employed to identify the circular features of circ_0038718, and the location of circ_0038718 in cells was detected via nucleocytoplasmic separation. Dual-luciferase reporter assay and RNA binding protein immunoprecipitation experiment were carried out to investigate the molecular mechanism of circ_0038718/miR-195-5p/Axin2. Additionally, MTT assay was conducted to assess cell proliferation; Transwell assay was performed to evaluate cell migration and invasion, respectively. The effect of circ_0038718 on CC tumor growth was tested through tumor formation in nude mice.

Results: circ_0038718 was highly expressed in CC and could sponge miR-195-5p in cytoplasm. Silencing circ_0038718 suppressed the proliferative, migratory and invasive abilities of CC cells, while the promoting effect of high circ_0038718 expression on CC cells was reversed upon miR-195-5p over-expression. Axin2 was a downstream target of miR-195-5p and could regulate the Wnt/β-catenin signaling pathway. Axin2 expression was modulated by circ_0038718/miR-195-5p. Knockdown of Axin2 could also attenuate the promoting effect of high circ_0038718 expression on CC cell malignant progression, thus inhibiting tumor growth.

Conclusion: circ_0038718 is able to facilitate CC cell malignant progression via the miR-195-5p/Axin2 axis, which will provide a new idea for finding a novel targeted treatment of CC.

Citing Articles

Analysis of miR-497/195 cluster identifies new therapeutic targets in cervical cancer.

Karunakara S, Eswaran S, Mallya S, Suresh P, Chakrabarty S, Kabekkodu S BMC Res Notes. 2024; 17(1):217.

PMID: 39095857 PMC: 11297691. DOI: 10.1186/s13104-024-06876-8.

Roles of circRNAs in the progression of colorectal cancer: novel strategies for detection and therapy.

Mao J, Lu Y Cancer Gene Ther. 2024; 31(6):831-841.

PMID: 38337038 DOI: 10.1038/s41417-024-00739-x.

Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells.

Ou Z, Lu Y, Xu D, Luo Z Front Immunol. 2023; 14:1271603.

PMID: 38035113 PMC: 10684956. DOI: 10.3389/fimmu.2023.1271603.

Hsa_circ_0001278 Facilitates Colorectal Cancer Progression Sponging miR-338-5p and Regulating AMOTL1 Expression.

Ge H, Yan Y, Wang H, Bian J, Deng Z, Su X Comb Chem High Throughput Screen. 2023; 28(1):99-109.

PMID: 38018210 DOI: 10.2174/0113862073265207231108052536.

Reveal the potential molecular mechanism of circRNA regulating immune-related mRNA through sponge miRNA in the occurrence and immune regulation of papillary thyroid cancer.

Wang B, Shen W, Yan L, Li X, Zhang L, Zhao S Ann Med. 2023; 55(2):2244515.

PMID: 37603701 PMC: 10443982. DOI: 10.1080/07853890.2023.2244515.

References

Sun M, Song H, Wang S, Zhang C, Zheng L, Chen F . Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer. J Hematol Oncol. 2017; 10(1):79. PMC: 5372308. DOI: 10.1186/s13045-017-0445-8. View

Jin W, Shi J, Liu M . Overexpression of miR-671-5p indicates a poor prognosis in colon cancer and accelerates proliferation, migration, and invasion of colon cancer cells. Onco Targets Ther. 2019; 12:6865-6873. PMC: 6709824. DOI: 10.2147/OTT.S219421. View

Jin C, Wang A, Liu L, Wang G, Li G . Hsa_circ_0136666 promotes the proliferation and invasion of colorectal cancer through miR-136/SH2B1 axis. J Cell Physiol. 2018; 234(5):7247-7256. DOI: 10.1002/jcp.27482. View

Li J, Ni S, Zhou C, Ye M . The expression profile and clinical application potential of hsa_circ_0000711 in colorectal cancer. Cancer Manag Res. 2018; 10:2777-2784. PMC: 6103302. DOI: 10.2147/CMAR.S172388. View

Yong W, Zhuoqi X, Baocheng W, Dongsheng Z, Chuan Z, Yueming S . Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer. Biomed Pharmacother. 2018; 102:1188-1194. DOI: 10.1016/j.biopha.2018.03.085. View

Chen S, Bu D, Ma Y, Zhu J, Chen G, Sun L . H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells. Neoplasia. 2017; 19(3):226-236. PMC: 5300698. DOI: 10.1016/j.neo.2016.10.007. View

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

Ng W, Mohidin T, Shukla K . Functional role of circular RNAs in cancer development and progression. RNA Biol. 2018; 15(8):995-1005. PMC: 6259826. DOI: 10.1080/15476286.2018.1486659. View

Cheng B, Rong A, Zhou Q, Li W . LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway. J Exp Clin Cancer Res. 2020; 39(1):5. PMC: 6942292. DOI: 10.1186/s13046-019-1510-7. View

10.

Wolpin B, Mayer R . Systemic treatment of colorectal cancer. Gastroenterology. 2008; 134(5):1296-310. PMC: 2528832. DOI: 10.1053/j.gastro.2008.02.098. View

11.

Feng Y, Xing Y, Liu Z, Yang G, Niu X, Gao D . Integrated analysis of microRNA and mRNA expression profiles in rats with selenium deficiency and identification of associated miRNA-mRNA network. Sci Rep. 2018; 8(1):6601. PMC: 5920094. DOI: 10.1038/s41598-018-24826-w. View

12.

Zheng R, Zeng H, Zhang S, Chen W . Estimates of cancer incidence and mortality in China, 2013. Chin J Cancer. 2017; 36(1):66. PMC: 5561600. DOI: 10.1186/s40880-017-0234-3. View

13.

Zheng X, Chen L, Zhou Y, Wang Q, Zheng Z, Xu B . A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. Mol Cancer. 2019; 18(1):47. PMC: 6440158. DOI: 10.1186/s12943-019-1010-6. View

14.

Jho E, Zhang T, Domon C, Joo C, Freund J, Costantini F . Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002; 22(4):1172-83. PMC: 134648. DOI: 10.1128/MCB.22.4.1172-1183.2002. View

15.

Chen Z, Ren R, Wan D, Wang Y, Xue X, Jiang M . Hsa_circ_101555 functions as a competing endogenous RNA of miR-597-5p to promote colorectal cancer progression. Oncogene. 2019; 38(32):6017-6034. DOI: 10.1038/s41388-019-0857-8. View

16.

Li T, Sun X, Chen L . Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker. J Cell Biochem. 2019; 121(3):2118-2126. DOI: 10.1002/jcb.28239. View

17.

Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J . The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019; 18(1):4. PMC: 6325825. DOI: 10.1186/s12943-018-0933-7. View

18.

Lordick F, Mossner J . [Current Standard Diagnosis and Treatment of Colon Cancer]. Dtsch Med Wochenschr. 2017; 142(7):487-490. DOI: 10.1055/s-0042-123913. View

19.

Xia H, Cao D, Yang F, Yang W, Li W, Liu P . Jiawei Yanghe decoction ameliorates cartilage degradation in vitro and vivo via Wnt/β-catenin signaling pathway. Biomed Pharmacother. 2020; 122:109708. DOI: 10.1016/j.biopha.2019.109708. View

20.

Luo J, Pan J, Jin Y, Li M, Chen M . MiR-195-5p Inhibits Proliferation and Induces Apoptosis of Non-Small Cell Lung Cancer Cells by Targeting CEP55. Onco Targets Ther. 2020; 12:11465-11474. PMC: 6935316. DOI: 10.2147/OTT.S226921. View